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Fulminant myocarditis in an adult with 2009 pandemic influenza
A (H1N1 influenza) infection
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Received June 28, 2010; accepted September 15, 2010AbstractThe worldwide outbreak of pandemic influenza A (H1N1 influenza) infection in 2009 caused numerous hospitalizations and deaths resulting
from severe complications such as pneumonia, sepsis, and acute respiratory distress syndrome. Fulminant myocarditis caused by H1N1 infection
has been reported in children but rarely in adults. We present an adult who contracted H1N1 infection followed by fulminant myocarditis. Early
implementation of extra-corporeal membrane oxygenation support in conjunction with a specific anti-influenza viral medication (Oseltamivir)
led to the patient’s complete recovery from cardiogenic shock in 2 weeks.
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Fulminant myocarditis may present as fatal arrhythmias,
atrioventricular (AV) block, various degrees of heart failure,
and cardiogenic shock, leading to a high mortality rate in acute
stage.1 Although various types of virus have been documented
to cause fulminant myocarditis, fulminant myocarditis caused
by pandemic influenza A (H1N1 influenza) infection has
rarely been reported, especially in adults. Herein, we report
an adult who had H1N1 infection complicated with acute
fulminant myocarditis and cardiogenic shock. By prompt
implementation of extra-corporeal membrane oxygenation
(ECMO) in conjunction with a specific anti-influenza medi-
cation (Oseltamivir), this patient completely recovered in 2
weeks.* Corresponding author. Dr. Tsu-Juey Wu, Cardiovascular Center, Taichung
Veterans General Hospital, 160, Section 3, Chung-Kang Road, Taichung 407,
Taiwan, ROC.
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In December 2009, a 44-year-old man was transferred to
our hospital due to fever and cough, following worsening
dyspnea for 5 days. He denied a history of cardiovascular
disease and any related risk factor. At the time of admission,
his blood pressure was low (85/50 mmHg) and the respiratory
rate was relatively high (22/min). Physical examination
revealed diffuse wheezing with crackle in breath sound, S3
gallop at the cardiac apex, jugular vein engorged, and bilateral
leg edema, suggestive of heart failure and cardiogenic shock.
Pulmonary edema with pleural effusion was evident on chest
film (Fig. 1A). Electrocardiograph (ECG) revealed sinus or
atrial rhythm with variable PP intervals and fixed RR intervals,
suggesting AV dissociation with left bundle branch block-like
junctional or ventricular rhythm (Fig. 2A). Laboratory data
showed elevated cardiac enzymes [creatine kinase 387 U/L
(normal range <160 U/L), creatine kinase MB 16 U/L (normal
range <16 U/L), cardiac troponin-I 12.0 ng/mL (normal range
<0.034 ng/mL)], liver enzymes [aspartate aminotransferasehinese Medical Association. All rights reserved.
Fig. 1. Chest films taken on (A) Day 1 and (B) Day 7 of hospitalization. Note that in A, pulmonary vasculature showed marked cephalization and interstitial edema.
Bilateral ground-glass pattern was compatible with the presence of pleural effusion. In B, severity of pulmonary edema and amount of pleural effusion were
significantly subsided.
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1497 U/L (normal range 4e44 U/L)], and serum creatinine
2.4 mg/dL (normal range 0.7e1.4 mg/dL), indicating a shock
status with multiple organ involvement. Coronary angiography
demonstrated normal coronary trees. However, the left ven-
triculogram disclosed global hypokinesis with an ejection
fraction of 27%.
Under the impression of fulminant myocarditis with
cardiogenic shock and probable AV block, ECMO and
transvenous temporary pacing were immediately imple-
mented. Since rapid influenza A antigen test showed a posi-
tive result, empirical anti-influenza medication with
Oseltamivir (75 mg twice daily) was concomitantly admin-
istrated for 5 days. A positive H1N1 influenza polymerase
chain reaction was subsequently confirmed during the
admission. On the second day of hospitalization, sinus
rhythm was rapidly restored with continuous left bundle
branch block but a narrower QRS complex (Fig. 2B). There
was no further evidence of AV dissociation or AV block.
Chest film on Day 7 showed diminished pulmonary edema
and less pleural effusion (Fig. 1B). All blood biochemical
parameters were progressively improved during hospital
course. Seven days after implementation of ECMO, trans-
thoracic echocardiogram (TTE) showed complete recovery
of left ventricular function except for the presence of a small
amount of pericardial effusion. The patient was successfully
weaned from ECMO without any complication. The patient
was discharged 2 weeks after admission.
3. Discussion
Viral infection remains the major cause of acute and
fulminant myocarditis. Among viruses, influenza A is an
extremely rare etiology.2,3 The Chinese cohort of 426 patients
who were hospitalized because of the 2009 pandemic influ-
enza A (H1N1 influenza) infection, elevated serum creatine
kinase and creatine kinase MB levels, which suggested cardiacinvolvement, were reported in 13% of patients.4 However,
cardiac involvement in this study was not routinely confirmed
by ECG, left ventriculogram, or endomyocardial biopsy.
Therefore, currently, the frequency of myocardial involvement
in patients with H1N1 infection remains unclear. Information
about the prevalence of H1N1 infection in Taiwan general
population was also limited.5,6 To date, only two adult patients
and seven children have been reported in the literature as
having acute fulminant myocarditis because of H1N1
infection.7e9
Although influenza-associated myocarditis carries a high
mortality rate in acute stage, the survivors have excellent
outcome when compared to individuals who contract other
types of acute viral myocarditis.3,10 However, during acute
stage, it is still unclear which medication is appropriate for
H1N1 infection complicated with myocarditis. In a series of
three patients with acute influenza-associated myocarditis
treated by ribavirin, two of them died shortly afterward,
while the other one died 8 months later despite rapidly
decline of viral titers.11 Intravenous immune globulin was
reported not to be superior to placebo in treating acute
fulminant myocarditis.12 In addition, steroid only showed
marginal benefit in improving the outcomes of acute fulmi-
nant myocarditis.13 In our patient, we used oseltamivir,
a neuraminidase inhibitor, as the empirical treatment for
H1N1 infection. Early administration of oral oseltamivir
increases the benefits of influenza treatment.14 However, its
effects on H1N1 myocarditis and outcomes deserve further
investigation.3
A previous study showed that ECMO was indicated in
patients with profound acute lung injury with hypoxia that
were refractory to mechanical ventilation support during
H1N1 infection. In the above study,15 acute lung injury
secondary to either viral pneumonia or secondary bacterial
infection universally prevailed in patients. In contrast, our
patient was free of acute lung injury. The purpose for using
ECMO in this particular case was circulatory/hemodynamic
Fig. 2. ECGs performed on (A) Day 1 and (B) Day 2 of hospitalization. Note that in A, ECG revealed sinus or atrial rhythm with variable PP intervals and fixed
RR intervals, suggesting AV dissociation with junctional or ventricular rhythm. Arrow heads indicate the identifiable P waves. In B, sinus rhythm with left bundle
branch block was observed. Arrow heads in lead I indicate the P waves. AV ¼ atrioventricular; ECG ¼ electrocardiogram.
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limited experiences in the use of ECMO in H1N1 infection
with fulminant myocarditis. In our case, we implemented
ECMO at a very early stage, resulting in a favorable outcome.
In conclusion, H1N1 infection can cause fulminant
myocarditis not only in children but also in adults, as in this
patient. In adult patients with acute fulminant myocarditis,
H1N1 influenza should be routinely screened as a potential
etiology. Aggressive cardiac support and the use of oseltamivir
are essential and may improve the outcome in such patients.Acknowledgments
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